These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36838925)

  • 1. Cancer Vaccines Based on Fluorine-Modified KH-1 Elicit Robust Immune Response.
    Liu Y; Li B; Zheng X; Xiong D; Ye X
    Molecules; 2023 Feb; 28(4):. PubMed ID: 36838925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and immunological evaluation of
    Zhai C; Zheng XJ; Song C; Ye XS
    RSC Med Chem; 2021 Jul; 12(7):1239-1243. PubMed ID: 34355188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorine-modified sialyl-Tn-CRM197 vaccine elicits a robust immune response.
    Song C; Zheng XJ; Guo H; Cao Y; Zhang F; Li Q; Ye XS; Zhou Y
    Glycoconj J; 2019 Oct; 36(5):399-408. PubMed ID: 31267246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and Evaluation of Glycoconjugates Comprising N-Acyl-Modified Thomsen-Friedenreich Antigens as Anticancer Vaccines.
    Sun S; Zheng XJ; Huo CX; Song C; Li Q; Ye XS
    ChemMedChem; 2016 May; 11(10):1090-6. PubMed ID: 27075633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cancer vaccine based on fluorine-modified sialyl-Tn induces robust immune responses in a murine model.
    Song C; Zheng XJ; Liu CC; Zhou Y; Ye XS
    Oncotarget; 2017 Jul; 8(29):47330-47343. PubMed ID: 28537884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative immunological studies of tumor-associated Lewis X, Lewis Y, and KH-1 antigens.
    Guo J; Jiang W; Li Q; Jaiswal M; Guo Z
    Carbohydr Res; 2020 Jun; 492():107999. PubMed ID: 32272238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constructing an adenocarcinoma vaccine: immunization of mice with synthetic KH-1 nonasaccharide stimulates anti-KH-1 and anti-Le(y) antibodies.
    Ragupathi G; Deshpande PP; Coltart DM; Kim HM; Williams LJ; Danishefsky SJ; Livingston PO
    Int J Cancer; 2002 May; 99(2):207-12. PubMed ID: 11979435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent development in carbohydrate-based cancer vaccines.
    Guo Z; Wang Q
    Curr Opin Chem Biol; 2009 Dec; 13(5-6):608-17. PubMed ID: 19766052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and immunological evaluation of N-acyl modified Tn analogues as anticancer vaccine candidates.
    Song C; Sun S; Huo CX; Li Q; Zheng XJ; Tai G; Zhou Y; Ye XS
    Bioorg Med Chem; 2016 Feb; 24(4):915-20. PubMed ID: 26787275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic and immunological studies of N-acyl modified S-linked STn derivatives as anticancer vaccine candidates.
    Huo CX; Zheng XJ; Xiao A; Liu CC; Sun S; Lv Z; Ye XS
    Org Biomol Chem; 2015 Mar; 13(12):3677-90. PubMed ID: 25679360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-associated carbohydrate antigens defining tumor malignancy: basis for development of anti-cancer vaccines.
    Hakomori S
    Adv Exp Med Biol; 2001; 491():369-402. PubMed ID: 14533809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoenzymatic synthesis and immunological evaluation of sialyl-Thomsen-Friedenreich (sTF) antigen conjugate to CRM197.
    Weng W; Ren S; Teng C; Guo J; Guo Q; Zhang W; Zong C; Ding N
    Bioorg Med Chem; 2024 Feb; 100():117615. PubMed ID: 38342079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient metabolic engineering of GM3 on tumor cells by N-phenylacetyl-D-mannosamine.
    Chefalo P; Pan Y; Nagy N; Guo Z; Harding CV
    Biochemistry; 2006 Mar; 45(11):3733-9. PubMed ID: 16533056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipopeptide-Coated Iron Oxide Nanoparticles as Potential Glycoconjugate-Based Synthetic Anticancer Vaccines.
    Sungsuwan S; Yin Z; Huang X
    ACS Appl Mater Interfaces; 2015 Aug; 7(31):17535-44. PubMed ID: 26200668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Advance in Tumor-associated Carbohydrate Antigens (TACAs)-based Antitumor Vaccines.
    Feng D; Shaikh AS; Wang F
    ACS Chem Biol; 2016 Apr; 11(4):850-63. PubMed ID: 26895482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbohydrate-monophosphoryl lipid a conjugates are fully synthetic self-adjuvanting cancer vaccines eliciting robust immune responses in the mouse.
    Wang Q; Zhou Z; Tang S; Guo Z
    ACS Chem Biol; 2012 Jan; 7(1):235-40. PubMed ID: 22013921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining synthetic carbohydrate vaccines with cancer cell glycoengineering for effective cancer immunotherapy.
    Qiu L; Gong X; Wang Q; Li J; Hu H; Wu Q; Zhang J; Guo Z
    Cancer Immunol Immunother; 2012 Nov; 61(11):2045-54. PubMed ID: 22539085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-Associated Extracellular Microvesicles with Fluorine-Modified Carbohydrate Antigens Trigger a Stronger Antitumor Immune Response.
    Mo J; Zou Y; Li BH; Li G; Zheng XJ; Liu Y; Ye XS
    ACS Appl Mater Interfaces; 2023 Aug; 15(34):40201-40212. PubMed ID: 37589474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cancer therapeutic vaccine based on clustered Tn-antigen mimetics induces strong antibody-mediated protective immunity.
    Richichi B; Thomas B; Fiore M; Bosco R; Qureshi H; Nativi C; Renaudet O; BenMohamed L
    Angew Chem Int Ed Engl; 2014 Oct; 53(44):11917-20. PubMed ID: 25168881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel cancer immunotherapy based on the combination of a synthetic carbohydrate-pulsed dendritic cell vaccine and glycoengineered cancer cells.
    Qiu L; Li J; Yu S; Wang Q; Li Y; Hu Z; Wu Q; Guo Z; Zhang J
    Oncotarget; 2015 Mar; 6(7):5195-203. PubMed ID: 25760071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.